Related Experiment Videos
[Brain natriuretic peptide. Diagnostic value in heart failure]
Joaquín Osca1, Anastasio Quesada, Miguel A Arnau
1Servicios de Cardiología, Hospital Universitario La Fe, Valencia, Spain. j_osca@inicia.es
Revista Espanola De Cardiologia
|January 11, 2002
Summary
Brain natriuretic peptide (BNP) levels correlate with heart failure (HF) severity and left ventricular dysfunction. However, BNP is not effective for differentiating between systolic and diastolic heart failure.
Area of Science:
- Cardiology
- Biochemistry
- Medical Diagnostics
Context:
- Heart failure (HF) management relies on identifying severity and cause.
- Brain natriuretic peptide (BNP) is a key biomarker in HF assessment.
- Understanding BNP's associations and diagnostic utility is crucial for clinical practice.
Purpose:
- To investigate the relationship between BNP levels and various clinical variables in HF patients.
- To assess the effectiveness of BNP in distinguishing between systolic and diastolic HF.
- To evaluate BNP's association with HF severity and left ventricular dysfunction.
Summary:
- BNP plasma levels demonstrated a significant positive correlation with HF functional class and left ventricular dysfunction.
- Associations were found between BNP and male sex, elevated creatinine, increased ventricular diameters, and pulmonary systolic pressure.
- Multivariate analysis confirmed BNP's independent relation to left systolic ventricular function, but a reliable cutoff for differentiating HF types was not identified.
Impact:
- BNP is a valuable indicator of HF severity and left ventricular dysfunction.
- Current data suggest BNP is not a suitable biomarker for differentiating systolic from diastolic HF.
- Further research may explore combined biomarkers for improved HF subtyping.